Kaleida Capital

Kaleida Capital is a San Diego-based venture capital firm established in 2022, specializing in early-stage investments within the fields of neuroscience and neurotechnology. The firm focuses on developing startups that are innovating in areas such as biopharma, clinical interventions, and emerging technologies aimed at advancing neuroscience. By concentrating on these sectors, Kaleida Capital aims to foster innovation and growth in the rapidly evolving landscape of neuroscience-related solutions.